Veno occlusive disease: update on clinical management (Q42909363)

10 November 2017

0 references

Veno occlusive disease: update on clinical management (English)

1 reference

10 November 2017

M Senzolo

1

1 reference

10 November 2017

G Germani

2

1 reference

10 November 2017

E Cholongitas

3

1 reference

10 November 2017

P Burra

4

1 reference

10 November 2017

A-K Burroughs

5

1 reference

10 November 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

World Journal of Gastroenterology

10 November 2017

1 reference

10 November 2017

13

1 reference

10 November 2017

29

1 reference

10 November 2017

3918-3924

1 reference

The transjugular route: the key hole to the liver world

10 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

Transjugular liver biopsy: how good is it for accurate histological interpretation?

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

Hepatic Veno-occlusive Disease (Sinusoidal Obstruction Syndrome) After Hematopoietic Stem Cell Transplantation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

Hepatic veno-occlusive disease as a result of a traditional remedy: confirmation of toxic pyrrolizidine alkaloids as the cause, using an in vitro technique

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease).

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

Plasma concentration monitoring of busulfan: does it improve clinical outcome?

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

The pathology, diagnosis, and treatment of hepatic veno-occlusive disease: current status and novel approaches

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

Venoocclusive disease of the liver following bone marrow transplantation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

Ursodiol does not prevent hepatic venoocclusive disease associated with Mylotarg therapy

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

Prognostic value of doppler-ultrasonography in hepatic veno-occlusive disease

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

"Silent" presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

Recombinant human tissue plasminogen activator for the treatment of severe hepatic veno-occlusive disease in pediatric bone marrow transplant patients.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

The syndrome of hepatic veno-occlusive disease after marrow transplantation.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171162

Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation

16 August 2018

1 reference

12 December 2020

The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation

1 reference

12 December 2020

Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study

1 reference

12 December 2020

Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients

1 reference

12 December 2020

Severe venoocclusive disease after liver transplantation treated with transjugular intrahepatic portosystemic shunt

1 reference

12 December 2020

Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

PGE1 accelerates thrombolysis by tissue plasminogen activator

1 reference

12 December 2020

Glutamine and vitamin E in the treatment of hepatic veno-occlusive disease following high-dose chemotherapy

1 reference

12 December 2020

Veno-occlusive disease of the liver associated with oral contraceptives: case report and review of literature

1 reference

12 December 2020

A phase I/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation

1 reference

12 December 2020

Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors

1 reference

12 December 2020

TIPS for veno-occlusive disease: is the contraindication real?

1 reference

12 December 2020

Ascites after transplantation--a mystery

1 reference

12 December 2020

Veno-occlusive disease of liver with nonportal type of cirrhosis, occurring in Jamaica

1 reference

12 December 2020

Color Doppler demonstration of segmental portal flow reversal: an early sign of hepatic veno-occlusive disease in an infant

1 reference

12 December 2020

Recombinant human tissue plasminogen activator for the treatment of established severe venocclusive disease of the liver after bone marrow transplantation

1 reference

12 December 2020

Hepatic outflow obstruction and liver failure due to leukemic cell infiltration in chronic lymphocytic leukemia

1 reference

12 December 2020

Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen

1 reference

12 December 2020

An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation

1 reference

12 December 2020

Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study

1 reference

12 December 2020

Defibrotide for the treatment of veno-occlusive disease after liver transplantation

1 reference

12 December 2020

MR imaging findings in a patient with hepatic veno-occlusive disease

1 reference

12 December 2020

Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation

1 reference

12 December 2020

Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemi

1 reference

12 December 2020

Pathogenesis of veno-occlusive liver disease after radiation

1 reference

12 December 2020

Serum tumor marker CA 125 is an early and sensitive indicator of veno-occlusive disease in children undergoing bone marrow transplantation

1 reference

12 December 2020

Transvenous liver biopsies in marrow transplant recipients

1 reference

12 December 2020

A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation

1 reference

12 December 2020

N-terminal peptide of type III procollagen: a marker for the development of hepatic veno-occlusive disease after BMT and a basis for determining the timing of prophylactic heparin

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V13.I29.3918

1 reference

10 November 2017

1 reference

10 November 2017

1 reference